The mechanism by which propofol induces pain on injection is still not known. A number of methods have been used to attenuate propofol-induced pain on injection 1 . The use of lignocaine to prevent pain associated with propofol injection is the most popular method used in clinical practice. The mechanism for this effect remains unclear. A local anaesthetic effect of lignocaine 2 or a decrease in pH of the propofol-lignocaine mixture compared with propofol alone 3 have been suggested. Eriksson et al suggested that pH changes might modify propofol injection pain by a mechanism different from the effect of the local anaesthetic on the vascular endothelium 3 . They showed that lignocaine mixed with propofol decreased its pH, resulting in a lower concentration of propofol in the aqueous phase and therefore less pain.
The mechanism by which propofol induces pain on injection is still not known. A number of methods have been used to attenuate propofol-induced pain on injection 1 . The use of lignocaine to prevent pain associated with propofol injection is the most popular method used in clinical practice. The mechanism for this effect remains unclear. A local anaesthetic effect of lignocaine 2 or a decrease in pH of the propofol-lignocaine mixture compared with propofol alone 3 have been suggested. Eriksson et al suggested that pH changes might modify propofol injection pain by a mechanism different from the effect of the local anaesthetic on the vascular endothelium 3 . They showed that lignocaine mixed with propofol decreased its pH, resulting in a lower concentration of propofol in the aqueous phase and therefore less pain.
Ketamine has a local anaesthetic action when administered intravenously for regional anaesthesia 4 . Pre-treatment with ketamine has proved effective in preventing propofol injection pain [5] [6] [7] . The pH values of pharmaceutical solutions of ketamine range from 3.5 to 5.5. We postulated that ketamine mixed with propofol could decrease the pH of mixed solution and reduce propofol injection pain in a mechanism similar to the addition of lignocaine.
In order to determine whether the change in pH achieved by adding ketamine to propofol, or the peripheral local anaesthetic effect of ketamine is the main mechanism for reduction of propofol injection pain by ketamine, we studied the difference in efficacy of adding ketamine to the propofol before injection of pre-treatment with ketamine under tourniquet before the propofol injection. The pH change caused by adding ketamine to the propofol solution was measured.
SUMMArY
The purpose of this study was to examine possible peripheral mechanisms for the reduction of propofol injection pain by the addition of ketamine. We hypothesised that pH changes associated with the addition of ketamine to propofol decrease propofol-induced pain on injection. We compared the efficacy of intravenous ketamine pretreatment under tourniquet with ketamine added to the propofol. In the pre-treatment group, patients received ketamine 10 mg in a total volume of 1.0 ml with 0.9% saline (n=94; Group P) under tourniquet for 30 seconds before administration of propofol after release of the tourniquet. In the mixture group, propofol 9 ml was mixed with ketamine 10 mg in 0.9% NaCl 1.0 ml (n=94, Group M). Pain was assessed with a four-point scale: 0=no pain, 1=mild pain, 2=moderate pain, 3=severe pain at the time of propofol injection. The pH of propofol, ketamine and a range of propofol-ketamine mixtures were also measured. Forty-eight patients (51%) in Group P complained of pain on injection compared with 28 patients (30%) in Group M (P=0.005). The pH of the 1% propofol-ketamine mixture was 5.84 while 1% propofol had a pH of 7.86. Our results support pH changes as a more important cause for the decrease in propofol injection pain with the addition of ketamine to propofol than a peripheral effect of ketamine. Anaesthesia 
METHoDS

Clinical study
The study was approved by the institutional review board of our hospital and written informed consent was obtained. This was a prospective, randomised and double-blinded comparison of ketamine pretreatment with ketamine/propofol mixture on propofol injection pain. A total of 188 adult patients (age range 18 to 65 years; ASA grade I or II) were recruited for the study. Exclusion criteria were: patients taking regular analgesic or opioids; patients with acute or chronic pain syndromes; patients under the influence of a sedative medication; and patients with problems with communication. No premedication was given.
on arrival of the patient in the operating room, a 20 g cannula was inserted into a vein on the dorsum of the patient's hand. Intraoperative physiologic monitoring included electrocardiography, noninvasive blood pressure measurement and pulse oximetry. The patients were randomly assigned to one of two groups using a sealed envelope method. Anaesthesia was induced and the data were collected by an anaesthesiologist who was unaware of the treatment assignment. group P (pretreatment) patients received a racemic mixture of ketamine 10 mg in 0.9% N/S 1.0 ml, followed by an infusion of propofol. group M (mixed) patients received N/S 1.0 ml pre-treatment, followed by an infusion of propofol (9 ml) mixed with ketamine 10 mg in N/S 1.0 ml. Identical coded syringes were prepared by a nurse not involved in the study. The pre-treatment dose was given intravenously distal to a rubber tourniquet on the upper forearm. The tourniquet was released after 30 seconds, after which propofol or propofol-ketamine mixture was administered. The first 5 ml bolus was given over 5 seconds; 15 seconds later, the patient was asked about the presence of injection pain. Pain on injection was assessed using a four-point scale 8 : 0=no pain, 1=mild pain (pain reported only in response to questioning), 2=moderate pain (pain reported in response to questioning and accompanied by a behavioural sign or pain reported spontaneously without questioning) and 3=severe pain (strong vocal response or response accompanied by facial grimacing, arm withdrawal or tears). The dose of ketamine used was based on the results of a previous study by Tan et al 5 that assessed the analgesic effect of ketamine on propofol injection pain.
After intravenous injection of the test treatment and release of the tourniquet, the injection of propofol continued until anaesthesia was fully induced. Anaesthesia was maintained with sevoflurane 1.0 to 2.0% and nitrous oxide 66% in oxygen. Emergence reactions defined as dreams, hallucinations and delirium were recorded by direct questioning after the patient recovered from the anaesthesia.
Bench study
We used propofol (1% Diprivan; AstraZeneca, Macclesfield, UK) and ketamine (Ketara; Huons, Seoul, Korea). The pH of 1% propofol, ketamine and the propofol-ketamine mixture was measured with a pH meter (Fisher scientific, PA, USA). A titration was also made to assess the effect on pH of increasing amounts of ketamine.
Statistical analysis
The sample size was determined to have a power of 80% at a 5% significance level (two-tailed) to detect a 20% difference in the incidence of injection pain between the two groups. The power analysis was based on data from a pilot study of 40 patients. Statistical comparisons between the two groups were carried out with the chi-squared test for proportions and with Student's t-test for continuous parametric data. Values of P <0.05 were considered statistically significant.
rESULTS
Clinical study
Both groups were comparable with respect to age, gender, weight and height ( Table 1 ). The overall incidence of injection pain was significantly lower in group M (28, 30%) compared with group P (48, 51%), P=0.005. The severity of injection pain, which was graded as none, mild, moderate or severe, showed a statistically significant benefit for Group P over group M (P=0.015) ( Table 2 ).
There were no significant differences in mean arterial pressure and heart rate between groups. The dose of ketamine used did not increase arterial blood pressure or prevent the propofol-induced decrease in arterial blood pressure that occurs before intubation. There were no emergence reactions.
Bench study
The pH of 1% propofol was 7.86 and the pH of ketamine was 4.08. The pH of the mixture of 1% propofol 9 ml with ketamine 10 mg in N/S 1.0 ml was 5.84. The pH of the propofol-ketamine mixture decreased in proportion to ketamine concentration ( Table 3) .
DISCUSSIoN
The overall incidence of injection pain was significantly lower in Group M (28 [30%] vs 48 [51%], P=0.005). This study demonstrates that a propofolketamine mixture (ketamine 10 mg in propofol 10 ml) is more effective than ketamine 10 mg pre-treatment in preventing pain associated with the intravenous administration of propofol. From the results of the in vitro study, we suggest the likely mechanism of the analgesic efficacy of the propofol-ketamine mixture may be the lower pH of the mixture compared with propofol alone.
The mechanism of pain on propofol injection remains unclear. A number of mechanisms have been proposed 3, [9] [10] [11] . Scott et al 11 suggested that the pain probably results from a direct irritant effect or an indirect effect via the kinin cascade. It has been suggested that the concentration of propofol in the aqueous phase may be an important variable for pain associated with propofol injection 9, 10 . By reducing the propofol concentration in the aqueous phase with intralipid, pain on injection was reduced 9 . recently, Eriksson et al 3 found that the pH of propofol decreased in a dose-dependent manner after mixing with 1% lignocaine. The concentration of propofol in the aqueous phase was lower when propofol was mixed with 1% lignocaine. Addition of lignocaine to propofol caused propofol to migrate from the aqueous phase of the propofol emulsion into its lipid phase. An increased proportion of propofol in the lipid phase caused less pain on injection.
The mechanism of the analgesic effect of ketamine is not clear. It has been suggested that the mechanism by which ketamine reduces pain on injection is related to an action on peripheral N-methyl-D-aspartate receptors 5 . Although it is possible that ketamine acts peripherally, our results suggest that pH change might have a greater role in reducing propofol injection pain. There was an inverse relationship between pH and the amount of ketamine added, similar to propofol-lignocaine mixtures. HCl mixed with propofol, which decreases the pH, reduces propofol-injection pain 3 .
Several studies have shown the use of ketamine to be effective. Pre-treatment with ketamine 10 mg significantly reduced the incidence of pain from 84 to 26% 5 . The results of this study suggest that ketamine modulated its effect at a peripheral site by a local action rather than a central analgesic effect because of the low dose used. Koo et al 7 reported that a small dose of ketamine, 100 μg/kg, given just before propofol injection, reduced the incidence and the intensity of injection pain more effectively than even smaller doses of ketamine (10 and 50 μg/kg) 7 . In contrast to our study, Koo et al reported that a propofol-ketamine mixture (ketamine 100 μg/kg) did not reduce propofol injection pain compared with saline pre-treatment. However, the ratio of the volume mixture was not described in that study. In our study, the incidence of injection pain in the pre-treatment group was approximately 51%, which was similar to that (46.7%) reported previously 7 .
our study has several limitations. We did not include a placebo group without ketamine administration. However, propofol is rarely given without analgesia in clinical practice because of the high incidence of injection pain, and our main focus was to find the primary mechanism of pain reduction by ketamine. We chose a dose of 10 mg The incidence and severity of pain were significantly different between the groups (P <0.05). of ketamine in all patients in the pre-treatment group based on Tan's study 12 . Pre-treatment with ketamine 10 mg 12 (approximately 100 to 150 μg/kg) or 100 μg/kg 7 has proved to have efficacy in preventing propofol infusion pain. Dosing of ketamine should not have been relevant to this study of local effects and allowed consistent pH effects of ketamine on the propofol mixture to be assessed. Larger doses of ketamine were not tested in order to minimise the likelihood of a significant central analgesic effect of ketamine.
Mixing of ketamine with the propofol dose compared with pre-treatment has the advantage of facilitating a simpler and faster injection sequence. It may increase the risk of adverse drug reactions to administer two drugs by mixing them together. Nonetheless, in the present study we did not find any adverse outcome after the use of propofolketamine mixtures, and on visual inspection we noted no colour change or immiscible surface layer.
Several methods have been tried to reduce the incidence of pain of propofol injection with variable success. The methods used to reduce this pain include the addition of lignocaine, using solutions at different temperatures, dilution of propofol, different sites of injection and various ways of combining ephedrine, ondansetron, metoclopramide, opioids, thiopentone or ketamine with the propofol injection sequence 1, 8, 11, 13, 14 . A quantitative systematic review by Picard and Tramer 1 concluded that the ideal method for prevention of propofol-associated pain is to give intravenous lignocaine 0.5 mg/kg while a tourniquet is applied to the forearm for a period of 30 to 120 seconds before injection of propofol. However, using this technique the failure rate was still 40%. Therefore, a combination therapy with two partially effective techniques has been recommended to solve this problem 15, 16 .
The most frequently mentioned adverse effect related to ketamine is emergence delirium or hallucinations. This occurs more commonly if ketamine is used as the sole agent for sedation and generally in higher doses than those used in this study. In the present study, no patient reported emergence reactions. The combination of ketamine with propofol may eliminate this effect of ketamine 17 .
In conclusion, a propofol-ketamine mixture was found to be more effective in decreasing the incidence of pain on injection of propofol than ketamine pre-treatment. our results support pH changes as a more important cause for the decrease in propofol injection pain with the addition of ketamine to propofol than a peripheral effect of ketamine.
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